Raúl Juntas‐Morales

Also affiliated with Inserm, Université de Montpellier, Vall d'Hebron Institut de Recerca, Centre for Biomedical Network Research on Rare Diseases, Hôpital Gui de Chauliac, Vall d'Hebron Hospital Universitari, ERN GUARD-Heart

MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study”.

Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study

Therapeutic Advances in Neurological Disorders(2024)10.1177/17562864241243186

N/A

0.992DataRank · unranked

38 citations

Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge, Channa Hewamadduma +23 more

Charcot-Marie-Tooth disease type 2CC due toNEFHvariants causes a progressive, non-length-dependent, motor-predominant phenotype

Journal of Neurology Neurosurgery & Psychiatry(2021)10.1136/jnnp-2021-327186

N/A

0DataRank · unranked

17 citations

Andrea Cortese, James M. Polke, Roy Poh, Jana Vandrovcová, Matilde Laurá +15 more